Note - The COVID-19 Vaccine Group is based on the interim recommendations from ACIP. As additional guidelines are published, the COVID-19 logic in ICE will be updated. This release includes support for the Pfizer COVID-19 vaccine (CVX 208), Moderna COVID-19 vaccine (CVX 207), and COVID-19, Unspecified Formulation (CVX 213).
Two Shot Same Day Exception Rules for COVID-19
The Duplicate Shot, Same Day rules do not apply for COVID-19 Vaccine Group, due to the fact that the absolute minimum intervals between dose 1 and dose 2 = 0 days in both the Pfizer COVID-19 2-dose Series and Moderna COVID-19 2-dose Series.
Panel | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
|
COVID-19 Vaccine Group Evaluation and Forecasting Rules
General Rules for COVID-19
General rules are not series-specific; general rules apply to the entire vaccine group.
...
borderColor | #CCFFFF |
---|---|
bgColor | #CCFFFF |
titleBGColor | #99FFFF |
borderStyle | solid |
...
This page specifies the COVID-19 logic implemented by ICE for recommendations before September 12, 2023.
For COVID-19 logic for recommendations as of September 12, 2023 onwards, see COVID-19 Vaccine Group - September 2023 Onwards.
Two Shot Same Day Exception Rules for COVID-19
For COVID-19 shots administered:
- before 10/25/2021, the Duplicate Shot, Same Day rules do NOT apply because absolute minimum intervals between dose 1 and dose 2 = 0 days (before 10/25/2021) in both the Pfizer COVID-19 2-dose series and Moderna COVID-19 2-dose series.
- on or after 10/25/2021, the Duplicate Shot, Same Day rules apply because absolute minimum intervals between dose 1 and dose 2 > 0 days (on or after 10/25/2021) in both the Pfizer COVID-19 2-dose series and Moderna COVID-19 2-dose series.
Panel | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
|
COVID-19 Vaccine Group Evaluation and Forecasting Rules
General Rules for COVID-19
General rules are not series-specific; general rules apply to the entire vaccine group.
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Anchor |
|
COVID-19 Vaccines
...
CVX Code
...
Name
...
Moderna COVID-19 Vaccine
...
208
...
Pfizer COVID-19 Vaccine
...
(*) If a COVID-19 vaccine is administered before the vaccine's minimum age or series' recommended age (16y - 4d for Pfizer; 18y - 4d for Moderna), or below the series' minimum interval, supplemental text is returned to alert the user of this fact even though the may have been evaluated as Valid. See "Special Series Rules" for both series below for more details. (Note: the running distribution must have the output_supplemental_text option enabled for the supplemental text to be returned.)
Combination Vaccines that Include COVID-19
...
Anchor |
|
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Notes
|
COVID-19 Vaccines
CVX Code | Name | Absolute Minimum Age | Absolute Maximum Age | Counts towards U.S. Vaccination |
---|---|---|---|---|
207 | Moderna COVID-19 Vaccine | 0 days | Yes | |
208 | Pfizer COVID-19 Vaccine | 0 days | Yes | |
210 | AstraZeneca COVID-19 Vaccine | 0 days | Yes | |
211 | Novavax COVID-19 Vaccine | 0 days | Yes | |
212 | Janssen COVID-19 Vaccine | 0 days | Yes | |
213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | 0 days | Yes | |
217 | Pfizer COVID-19 Vaccine (>= 12 years) | 0 days | Yes | |
218 | Pfizer COVID-19 Vaccine | 0 days | 18 years - 1 day | Yes |
219 | Pfizer COVID-19 Vaccine | 0 days | 6 years - 1 day | Yes |
221 | Moderna COVID-19 Vaccine | 0 days | Yes | |
227 | Moderna COVID-19 Vaccine (Inactive) | 0 days | 13 years - 1 day | Yes |
228 | Moderna COVID-19 Vaccine | 0 days | 7 years - 1 day | Yes |
229 | Moderna COVID-19 Vaccine, Bivalent | 0 days | Yes | |
230 | Moderna, COVID-19 Vaccine, Bivalent Booster | 0 days | 7 years - 1 day | Yes |
300 | Pfizer COVID-19 Vaccine, Bivalent | 0 days | Yes | |
301 | Pfizer COVID-19 Vaccine, Bivalent | 0 days | 12 years - 1 day | Yes |
302 | Pfizer, COVID-19 Vaccine, Bivalent | 0 days | 6 years - 1 day | |
500 | COVID-19 Non-US Vaccine, Product Unknown | No | ||
501 | COVID-19 IV Non-US Vaccine (QAZCOVID-IN) | No | ||
502 | COVID-19 IV Non-US Vaccine (COVAXIN) | 0 days | Yes | |
503 | COVID-19 LAV Non-US Vaccine (COVIVAC) | No | ||
504 | COVID-19 VVnr Non-US Vaccine (Sputnik Light) | No | ||
505 | COVID-19 VVnr Non-US Vaccine (Sputnik V) | No | ||
506 | COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology) | No | ||
507 | COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbology Chinese academy of Sciences) | No | ||
508 | COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) | No | ||
509 | COVID-19 PS Non-US Vaccine (EpiVacCorona) | No | ||
510 | COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) | 0 days | Yes | |
511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | 0 days | Yes | |
512 | COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) | 18 years - 4 days | Yes | |
513 | COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) | No | ||
514 | COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) | No | ||
515 | COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) | No | ||
516 | COVID-19 Inactivated Non-US Vaccine (Minhai Biotechnology Co, KCONVAC) | No | ||
517 | COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) | No | ||
518 | COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) | No | ||
519 | COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna | 0 days | Yes | |
520 | COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech | 0 days | Yes | |
521 | COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK | No |
Combination Vaccines that Include COVID-19
No combination vaccines exist, at this time, that include COVID-19 and count toward completion of the Pfizer COVID-19 2-dose series.
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
CVX Code Specific RulesCVX Code Absolute Minimum Age
CVX Code Absolute Maximum Age
Rule for CVX 218, CVX 219, CVX 227, CVX 228, CVX 229, CVX 230, CVX 301, CVX 302
Rule for Bivalent Vaccines (CVX 229, CVX 230, CVX 300, CVX 301, CVX 301, CVX 519, CVX 520)
Rule for CVX 213
Rules for COVID-19 Vaccines Not Authorized by FDA2The following set of rules apply to 1) COVID-19 Vaccines Not Authorized by FDA, but Authorized by WHO and, 2) COVID-19 Vaccines Not Authorized by FDA or WHO, but is an Active COVID-19 Vaccine Candidate as part of a U.S.-based Clinical Trial of a COVID-19 Vaccine.
|
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Notes
|
Immunization Series and Selection Rules
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Series Name
Series Selection RulesThere are five series for this vaccine group: Pfizer COVID-19 Series, Moderna COVID-19 Series, Mixed Product COVID-19 Series, Janssen COVID-19 Series, and Novavax COVID-19 Series. The rules for determining which series applies are:
|
Immunization Series: Pfizer COVID-19 Series
The Pfizer COVID-19 Series is complete after 2 or 3 doses, depending on age (not including booster dose(s)).
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum Age | Minimum Age | Routine Age | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Pfizer COVID-19 Series | 0 days | 6 months | 6 months | N/A | 208, 217, 218, 219, 300, 301, 302 | 229, 230 |
2 | Pfizer COVID-19 Series | 0 days | 6 months | 6 months | N/A | 208, 217, 218, 219, 300, 301, 302 | 229, 230 |
3 | Pfizer COVID-19 Series | 0 days | 6 months | 6 months | N/A | 208, 217, 218, 219, 300, 301, 302 | 229, 230 |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Pfizer COVID-19 Series | 8 weeks - 4 days if dose 2 administered >= 4/19/2023 and dose 1 administered >= 5 years of age Otherwise, 17 days | 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age Otherwise, 21 days | 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age Otherwise, 21 days |
N/A |
Dose 2 to 3 | Pfizer COVID-19 Series | 8 weeks - 4 days | 8 weeks | 8 weeks | N/A |
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Series Special Rules
Vaccine to Recommend
Skip Dose Rule
Rule for CVX 212 (Janssen COVID-19 vaccine)
|
Immunization Series: Moderna COVID-19 Series
The Moderna COVID-19 series is complete after 2 doses(not including booster dose(s)).
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Moderna COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 221, 227, 228, 229 | N/A |
2 | Moderna COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 221, 227, 228, 229 | N/A |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Moderna COVID-19 | 0 days if dose 2 administered < 10/25/2021 8 weeks - 4 days if dose 2 administered >= 4/19/2023 and dose 1 administered >= 6 years of age Otherwise, 24 days if dose 2 administered >= 10/25/2021 | 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 6 years of age Otherwise, 28 days | 8 weeks if the execution date is >= 4/19/2023 and dose 1 administered >= 6 years of age Otherwise, 28 days | N/A |
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Series Special Rules
Vaccine to Recommend
Rule for CVX 212 (Janssen COVID-19 vaccine)
|
Immunization Series: Mixed Product COVID-19 Series
The Mixed Product COVID-19 Series is complete after 2 or 3 doses, depending on age(not including booster dose(s)).
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Mixed Product COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 208, 211, 213, 217, 218, 219, 221, 227, 228, 300, 301, 302 | 229, 230 |
2 | Mixed Product COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 208, 211, 213, 217, 218, 219, 221, 227, 228, 300, 301, 302 | 229, 230 |
3 | Mixed Product COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 208, 211, 213, 217, 218, 219, 221, 227, 228, 300, 301, 302 | 229, 230 |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Mixed Product COVID-19 Series | 8 weeks - 4 days if dose 2 administered >= 4/19/2023 and dose 1 administered >= 5 years of age Otherwise:
| 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age Otherwise, 28 days | 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age Otherwise, 28 days | N/A |
Dose 2 to 3 | Mixed Product COVID-19 Series | 8 weeks - 4 days | 8 weeks | 8 weeks | N/A |
...
Doses
...
Series Name
...
Absolute Minimum Interval
...
Minimum Recommended Interval
...
Dose 1 to 2
...
Pfizer COVID-19 2-dose Series
...
0 days
...
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
CVX Code Specific RulesCVX Code Absolute Minimum Age
Rule for CVX 213
|
Immunization Series and Selection Rules
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Series Name
Series Selection RulesThere are two series for this vaccine group: the Pfizer COVID-19 2-dose series and the Moderna COVID-19 2-dose series. The rules for determining which series applies are:
|
Immunization Series: Pfizer COVID-19 2-dose Series
The Pfizer COVID-19 2dose series is complete after 2 doses.
Vaccine Dose Parameters - Minimum and Routine Ages
...
Dose
...
Series Name
...
Absolute Minimum
Age
...
Routine
Age
...
1
...
Pfizer COVID-19 2-dose Series
...
0 days
...
2
...
Pfizer COVID-19 2-dose Series
...
0 days
...
16 years
...
Vaccine Dose Parameters - Minimum and Recommended Intervals
Series Special Rules
Vaccine to Recommend
Skip Dose Rule
Rule for CVX 211 (Novavax COVID-19 vaccine)
Rule for CVX 212 (Janssen COVID-19 vaccine)
|
Immunization Series: Janssen COVID-19 Series
The Janssen COVID-19 Series is complete after 1 dose.
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Janssen COVID-19 Series | 0 days | 18 years | 18 years | N/A | 212 | N/A |
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Series Special Rules
|
Immunization Series:
...
Novavax COVID-19
...
Series
The Moderna Novavax COVID-19 2-dose series Series is complete after 2 doses. 2 doses (not including booster dose(s)).
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 |
Novavax COVID-19 |
Series |
12 years - 4 days |
12 years |
12 years | N/A |
211 | |
2 |
Novavax COVID-19 |
Series |
12 years - 4 days |
12 years |
12 years | N/A |
N/A
211 |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 |
Moderna COVID-19 2-dose Series
0 days
28 days
...
borderColor | #CCFFFF |
---|---|
bgColor | #CCFFFF |
titleBGColor | #99FFFF |
borderStyle | solid |
Series Special Rules
...
Novavax COVID-19 Series | 17 days | 21 days | 21 days | 8 weeks |